Literature DB >> 29876623

[Phytotherapy for benign prostatic hyperplasia].

Friedemann Zengerling1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29876623     DOI: 10.1007/s00120-018-0687-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  7 in total

1.  A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors:  Fatih Hizli; M Cemil Uygur
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

3.  Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.

Authors:  Young Woo Ryu; Song Won Lim; Jung Hoon Kim; Seung Hyun Ahn; Jae Duck Choi
Journal:  Urol Int       Date:  2015-01-23       Impact factor: 2.089

4.  Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Authors:  Frans Debruyne; Gary Koch; Peter Boyle; Fernando Calais Da Silva; Jay G Gillenwater; Freddie C Hamdy; Paul Perrin; Pierre Teillac; Remigio Vela-Navarrete; Jean-Pierre Raynaud
Journal:  Eur Urol       Date:  2002-05       Impact factor: 20.096

5.  Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.

Authors:  Remigio Vela-Navarrete; Antonio Alcaraz; Alfredo Rodríguez-Antolín; Bernardino Miñana López; Jesús M Fernández-Gómez; Javier C Angulo; David Castro Díaz; Javier Romero-Otero; Francisco J Brenes; Joaquín Carballido; José Mª Molero García; Antonio Fernández-Pro Ledesma; José Manuel Cózar Olmos; José Manasanch Dalmau; Isaac Subirana Cachinero; Michael Herdman; Vincenzo Ficarra
Journal:  BJU Int       Date:  2018-06-06       Impact factor: 5.588

Review 6.  Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.

Authors:  Celeste De Monte; Simone Carradori; Arianna Granese; Giovanni Battista Di Pierro; Costantino Leonardo; Cosimo De Nunzio
Journal:  BMC Urol       Date:  2014-08-11       Impact factor: 2.264

Review 7.  Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Giacomo Novara; Gianluca Giannarini; Antonio Alcaraz; José-M Cózar-Olmo; Aurelien Descazeaud; Francesco Montorsi; Vincenzo Ficarra
Journal:  Eur Urol Focus       Date:  2016-04-23
  7 in total
  1 in total

Review 1.  [Phosphodiesterase inhibitors for the treatment of benign prostatic hyperplasia].

Authors:  Friedemann Zengerling
Journal:  Urologe A       Date:  2019-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.